Kelly R. Thornburg
Corporate Officer/Principal presso CHIMERIC THERAPEUTICS LIMITED
Posizioni attive di Kelly R. Thornburg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 03/02/2022 | - |
Storia della carriera di Kelly R. Thornburg
Precedenti posizioni note di Kelly R. Thornburg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| XBIOTECH INC. | Direttore operativo | 08/06/2015 | 05/05/2017 |
| KITE PHARMA INC | Corporate Officer/Principal | - | - |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Formazione di Kelly R. Thornburg
| Rockhurst University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Australia | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| XBIOTECH INC. | Health Technology |
| AMGEN INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Borsa valori
- Insiders
- Kelly R. Thornburg
- Esperienza
